AstraZeneca's Initial Vaccine Volumes in Europe to Be Lower Than Expected
By Adriano Marchese
AstraZeneca PLC said Friday that initial Covid-19 vaccine
volumes in Europe will be lower than anticipated in January.
"While there is no scheduled delay to the start of shipments of
our vaccine should we receive approval in Europe, initial volumes
will be lower than originally anticipated," a spokesperson for the
pharmaceutical company said.
AstraZeneca blamed the lower volumes on reduced yields at a
manufacturing site within its European supply chain.
"We will be supplying tens of millions of doses in February and
March to the European Union, as we continue to ramp up production
volumes," the spokesperson added.
Write to Adriano Marchese at email@example.com
(END) Dow Jones Newswires
January 22, 2021 13:54 ET (18:54 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.